Analysts’ Viewpoint on Interspinous Spacers Market Scenario
Increase in geriatric population, surge in demand for minimally invasive devices, and rise in product launches are driving the global interspinous spacers market. The risk of degenerative disc disorder and lumbar spinal disorder increases with age. Lumbar spinal stenosis (LSS) is the most common reason for spine surgery in people over 65 years. Interspinous spacer (vertiflex spacer) is used in the treatment of pain related to LSS. Key players in the global interspinous spacers market have invested significantly in R&D to develop and launch interspinous spacers. A series of product launches and commercialization has been witnessed over the last few years across the globe. However, high rate of reoperation risk after implantation of interspinous spacers is anticipated to restrain the global market.
Interspinous spacer is a device implanted between two interspinous processes to create space between nerve channels. This procedure is used as a minimally invasive surgery alternative to surgical procedures used to decompress the spinal canal. Spinal stenosis is most commonly caused by wear and tear in the spine due to osteoarthritis. In severe cases of spinal stenosis, doctors recommend minimally invasive surgery to create additional space for the spinal cord or nerves. Various organizations such as the World Health Organization (WHO) and Population Reference Bureau indicate that the percentage of population aged above 50 is increasing at a steady pace compared to the geriatric population. A report published by WHO revealed that the number of people aged 65 years or older is expected to increase from 605 million in 2012 to 2 billion by 2050. Moreover, the Population Reference Bureau (PRB) suggested that the geriatric population in regions such as Europe and Asia Pacific is rising rapidly compared to other developed or developing regions due to low fertility rate. Innovative product launches and their commercialization across the globe are anticipated to augment the global interspinous spacers market. Globally, physicians and surgeons are opting for minimally invasive surgery for spinal pain management. These procedures are gaining popularity over conventional surgeries, such as spinal fusion procedures, in the treatment of LSS, degenerative disc disease, and other related disorders.
The COVID-19 pandemic has had a negative impact on the global interspinous spacers market. Governments of affected countries deferred non-essential surgeries and patient visits during the breakout year of COVID-19. Several ICU facilities, such as ventilators, personal protective equipment, and medical staff, were rerouted to COVID-19 cases, prompting the suspension of spinal surgery during the pandemic. This led to substantial decline in overall non-emergency surgeries and treatments, which in turn restricted the usage of vertiflex spacers in spinal pain management. Key players reported decline in revenue due to the pandemic, which led to a decrease in Y-o-Y market share in the interspinous spacers market. However, the market has recovered from COVID-19 due to easing of restrictions by countries across the globe.
The static segment accounted for major market share for interspinous spacers in 2021. Low cost of static spacers, product launches, and favorable reimbursement policies are anticipated to augment the segment during the forecast period. For instance, in April 2022, Spinal Simplicity, a medical device company, announced the launch of the Minuteman G5 implant. Minuteman is a minimally invasive, interspinous interlaminar fusion device intended for the fixation and stabilization of the thoracic, lumbar, and sacral spine, while awaiting bony fusion to occur. Static interspinous spacers are the primary choice of surgeons owing to their multiple advantages such as low cost spacers. Reports claim that over 11,000 X STOP implants have been inserted worldwide, since X STOP received approval from the U.S. Food and Drug Administration (FDA).
In terms of indication, the lumbar spinal stenosis segment is projected to dominate the global market during the forecast period. Increase in geriatric population, high prevalence of LSS among the population aged above 60, and high adoption of minimally invasive surgery procedures are the factors likely to drive the segment during the forecast period. For instance, 250,000 to 500,000 U.S. residents are affected by symptoms of spinal stenosis. This indicates that around 1 in 1,000 people older than 65 years and 5 in 1,000 people older than 50 years of age are affected with spinal stenosis. LSS is the leading preoperative diagnosis for adults older than 65 who undergo spine surgery. According to a United Nations report, around 128 million people in China are above 60 years of age, which is higher than Japan’s entire population. By the end of 2050, China could have around 400 million people aged above 60 years. Hence, surge in the geriatric population is likely to increase the prevalence of LSS.
North America is projected to be a highly lucrative region of the global market during the forecast period. The region accounted for the largest share of the global market in 2021. High prevalence of degenerative disc disorders and spinal stenosis; and presence of technologically advanced countries are the factors propelling the market in North America. The U.S. dominates the market in North America and is anticipated to sustain its leadership position during the forecast period due to large number of patients with degenerative disc disorders and favorable reimbursement for interspinous spacer devices. Additionally, increase in LSS in the geriatric population is driving the demand for interspinous spacers in the U.S.
Europe was the second-largest interspinous spacers market in 2021. Favorable regulatory and reimbursement scenario, approval of products, and presence of large geriatric population and people with spine disabilities are likely to propel the interspinous spacers market in the region.
The market in Asia Pacific is projected to grow at a significantly high CAGR during the forecast period owing to the increase in geriatric population in countries such as Japan and China, higher incidence rates of LSS & degenerative disc diseases, rise in per capita income, and improving healthcare infrastructure. Moreover, growth in healthcare expenditure and rise in investments by key players in the interspinous spacers market in emerging economies are expected to propel the market in the region.
The interspinous spacers market report includes vital information about the key players operating in the global market. Companies are focusing on strategies such as product launches, divestiture, mergers & acquisitions (M&A), and partnerships to strengthen their position in the market. Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc. are the prominent players operating in the global market.
Each of these players in the interspinous spacers market has been profiled in the report based on parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.
Attribute |
Detail |
Market Size Value in 2021 |
US$ 70.94 Mn |
Market Forecast Value in 2031 |
More than US$ 127.33 Mn |
Compound Annual Growth Rate (CAGR) |
6.09% |
Forecast Period |
2022–2031 |
Historical Data Available for |
2017–2021 |
Quantitative Units |
US$ Mn for Value |
Market Analysis |
It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
Competition Landscape |
|
Format |
Electronic (PDF) + Excel |
Market Segmentation |
|
Regions Covered |
|
Countries Covered |
|
Companies Profiled |
|
Customization Scope |
Available upon request |
Pricing |
Available upon request |
The global interspinous spacers market was valued at US$ 70.94 Mn in 2021
The global market is projected to reach more than US$ 127.33 Mn by 2031
The global interspinous spacers market grew at a CAGR of 1.63% from 2017 to 2021
The global interspinous spacers market is anticipated to grow at a CAGR of 6.09% from 2022 to 2031
Rise in demand for minimally invasive surgeries and increase in the global geriatric population
The static segment held the largest share of around 57% of the market in terms of revenue in 2021
North America is expected to account for major share of the global interspinous spacers market during the forecast period
Medtronic, NuVasive, Inc., Paradigm Spine (RTI Surgical), Zimmer Biomet, Vertiflex, Inc., Life Spine, Inc., and Globus Medical, Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Interspinous Spacer Market
4. Market Overview
4.1. Introduction
4.1.1. Product Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Interspinous Spacer Market Analysis and Forecast, 2022–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key product/brand Analysis
5.3. Overview of Strategies Adopted by Top Players
6. Global Interspinous Spacer Market Analysis and Forecast, by Spacer Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Spacer Type, 2022–2031
6.3.1. Static (Compressible) Spacers
6.3.2. Dynamic (Non-compressible) Spacers
6.4. Market Attractiveness Analysis, by Spacer Type
7. Global Interspinous Spacer Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2022–2031
7.3.1. Lumbar Spinal Stenosis
7.3.2. Degenerative Disc Disease
7.3.3. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Interspinous Spacer Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by End-user, 2022–2031
8.3.1. Hospitals
8.3.2. Ambulatory Surgery Centers
8.3.3. Orthopedic Clinics
8.4. Market Attractiveness Analysis, by End-user
9. Global Interspinous Spacer Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Sub-region
10. North America Interspinous Spacer Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Spacer Type, 2022–2031
10.2.1. Static (Compressible) Spacers
10.2.2. Dynamic (Non-compressible) Spacers
10.3. Market Value Forecast, by Application, 2022–2031
10.3.1. Lumbar Spinal Stenosis
10.3.2. Degenerative Disc Disease
10.3.3. Others
10.4. Market Value Forecast, by End-user, 2022–2031
10.4.1. Hospitals
10.4.2. Ambulatory Surgery Centers
10.4.3. Orthopedic Clinics
10.5. Market Value Forecast, by Country, 2022–2031
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Spacer Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Interspinous Spacer Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Spacer Type, 2022–2031
11.2.1. Static (Compressible) Spacers
11.2.2. Dynamic (Non-compressible) Spacers
11.3. Market Value Forecast, by Application, 2022–2031
11.3.1. Lumbar Spinal Stenosis
11.3.2. Degenerative Disc Disease
11.3.3. Others
11.4. Market Value Forecast, by End-user, 2022–2031
11.4.1. Hospitals
11.4.2. Ambulatory Surgery Centers
11.4.3. Orthopedic Clinics
11.5. Market Value Forecast, by Country/Sub-region, 2022–2031
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Spacer Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Interspinous Spacer Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Spacer Type, 2022–2031
12.2.1. Static (Compressible) Spacers
12.2.2. Dynamic (Non-compressible) Spacers
12.3. Market Value Forecast, by Application, 2022–2031
12.3.1. Lumbar Spinal Stenosis
12.3.2. Degenerative Disc Disease
12.3.3. Others
12.4. Market Value Forecast, by End-user, 2022–2031
12.4.1. Hospitals
12.4.2. Ambulatory Surgery Centers
12.4.3. Orthopedic Clinics
12.5. Market Value Forecast, by Country/Sub-region, 2022–2031
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Spacer Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Interspinous Spacer Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Spacer Type, 2022–2031
13.2.1. Static (Compressible) Spacers
13.2.2. Dynamic (Non-compressible) Spacers
13.3. Market Value Forecast, by Application, 2022–2031
13.3.1. Lumbar Spinal Stenosis
13.3.2. Degenerative Disc Disease
13.3.3. Others
13.4. Market Value Forecast, by End-user, 2022–2031
13.4.1. Hospitals
13.4.2. Ambulatory Surgery Centers
13.4.3. Orthopedic Clinics
13.5. Market Value Forecast, by Country/Sub-region, 2022–2031
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Spacer Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Interspinous Spacer Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Spacer Type, 2022–2031
14.2.1. Static (Compressible) Spacers
14.2.2. Dynamic (Non-compressible) Spacers
14.3. Market Value Forecast, by Application, 2022–2031
14.3.1. Lumbar Spinal Stenosis
14.3.2. Degenerative Disc Disease
14.3.3. Others
14.4. Market Value Forecast, by End-user, 2022–2031
14.4.1. Hospitals
14.4.2. Ambulatory Surgery Centers
14.4.3. Orthopedic Clinics
14.5. Market Value Forecast, by Country/Sub-region, 2022–2031
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Spacer Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis By Company (2021)
15.3. Company Profiles
15.3.1. Medtronic
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. NuVasive, Inc.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Paradigm Spine (RTI Surgical)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. Zimmer Biomet
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Vertiflex, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Life Spine, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Globus Medical, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
List of Tables
Table 1: Incidence of Low Back Pain and Degenerative Spine Disease Worldwide, by World Bank Income Group
Table 2: Incidence of Low Back Pain and Degenerative Spine Disease Worldwide, by WHO Region
Table 3: Incidence of Disc Degeneration and Spinal Stenosis Worldwide, by World Bank Income Group
Table 4: Incidence of Disc Degeneration and Spinal Stenosis Worldwide, by Region
Table 5: Global Interspinous Spacers Market Value (US$ Mn) Forecast, by Product, 2022–2031
Table 6: Global Interspinous Spacers Market Value (US$ Mn) Forecast, by Indication, 2022–2031
Table 7: Global Interspinous Spacers Market Value (US$ Mn) Forecast, by End-user, 2022–2031
Table 8: Global Interspinous Spacers Market Value (US$ Mn) Forecast, by Region, 2022–2031
Table 9: North America Interspinous Spacers Market Value (US$ Mn) Forecast, by Country, 2022–2031
Table 10: North America Interspinous Spacers Market Value (US$ Mn) Forecast, by Product, 2022–2031
Table 11: North America Interspinous Spacers Market Value (US$ Mn) Forecast, by Indication, 2022–2031
Table 12: North America Interspinous Spacers Market Value (US$ Mn) Forecast, by End-user, 2022–2031
Table 13: Europe Interspinous Spacers Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2022–2031
Table 14: Europe Interspinous Spacers Market Value (US$ Mn) Forecast, by Product, 2022–2031
Table 15: Europe Interspinous Spacers Market Value (US$ Mn) Forecast, by Indication, 2022–2031
Table 16: Europe Interspinous Spacers Market Value (US$ Mn) Forecast, by End-user, 2022–2031
Table 17: Asia Pacific Interspinous Spacers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2031
Table 18: Asia Pacific Interspinous Spacers Market Value (US$ Mn) Forecast, by Product, 2022–2031
Table 19: Asia Pacific Interspinous Spacers Market Value (US$ Mn) Forecast, by Indication, 2022–2031
Table 20: Asia Pacific Interspinous Spacers Market Value (US$ Mn) Forecast, by End-user, 2022–2031
Table 21: Latin America Interspinous Spacers Market Value (US$ Mn) Forecast, by Country/Sub-region, 2022–2031
Table 22: Latin America Interspinous Spacers Market Value (US$ Mn) Forecast, by Product, 2022–2031
Table 23: Latin America Interspinous Spacers Market Value (US$ Mn) Forecast, by Indication, 2022–2031
Table 24: Latin America Interspinous Spacers Market Value (US$ Mn) Forecast, by End-user, 2022–2031
List of Figures
Figure 01: Global Interspinous Spacers Market Value (US$ Mn) Forecast, 2022–2031
Figure 02: Global Interspinous Spacers Market Value Share (%), by Product (2021)
Figure 03: Global Interspinous Spacers Market Value Share (%), by Indication (2021)
Figure 04: Global Interspinous Spacers Market Value Share (%), by Region (2021)
Figure 05: Global Interspinous Spacers Market Value Share (%), by End-user (2021 )
Figure 06: Global Interspinous Spacers Market Value Share (%), by Product, 2021 and 2031
Figure 07: Global Interspinous Spacers Market Attractiveness Analysis, by Product, 2022–2031
Figure 08: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Static Spacers, 2022–2031
Figure 09: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Dynamic Spacers, 2022–2031
Figure 10: Global Interspinous Spacers Market Value Share (%), by Indication, 2021 and 2031
Figure 11: Global Interspinous Spacers Market Attractiveness Analysis, by Indication, 2022–2031
Figure 12: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Lumbar Spinal Stenosis, 2022–2031
Figure 13: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Degenerative Disc Disease, 2022–2031
Figure 14: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Others, 2022–2031
Figure 15: Global Interspinous Spacers Market Value Share Analysis (%), by End-user, 2021 and 2031
Figure 16: Global Interspinous Spacers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 17: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Hospitals, 2022–2031
Figure 18: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Orthopedic Clinics, 2022–2031
Figure 19: Global Interspinous Spacers Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, by Ambulatory Surgery Centers, 2022–2031
Figure 20: Global Interspinous Spacers Market Value Share (%), by Region, 2021 and 2031
Figure 21: Global Interspinous Spacers Market Attractiveness Analysis, by Region, 2022–2031
Figure 22: North America Interspinous Spacers Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 23: North America Interspinous Spacers Market Value Share, by Country, 2021 and 2031
Figure 24: North America Interspinous Spacers Market Attractiveness Analysis, by Country, 2022-2031
Figure 25: North America Interspinous Spacers Market Value Share Analysis (%), by Product, 2021 and 2031
Figure 26: North America Interspinous Spacers Market Attractiveness Analysis, by Product, 2022–2031
Figure 27: North America Interspinous Spacers Market Value Share (%), by Indication, 2021 and 2031
Figure 28: North America Interspinous Spacers Market Attractiveness Analysis, by Indication, 2022–2031
Figure 29: North America Interspinous Spacers Market Value Share (%), by End-user, 2021 and 2031
Figure 30: North America Interspinous Spacers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 31: Europe Interspinous Spacers Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 32: Europe Interspinous Spacers Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 33: Europe Interspinous Spacers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 34: Europe Interspinous Spacers Market Value Share (%), by Product, 2021 and 2031
Figure 35: Europe Interspinous Spacers Market Attractiveness Analysis, by Product, 2022–2031
Figure 36: Europe Interspinous Spacers Market Value Share (%), by Indication, 2021 and 2031
Figure 37: Europe Interspinous Spacers Market Attractiveness Analysis, by Indication, 2022–2031
Figure 38: Europe Interspinous Spacers Market Value Share (%), by End-user, 2021 and 2031
Figure 39: Europe Interspinous Spacers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 40: Asia Pacific Interspinous Spacers Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 41: Asia Pacific Interspinous Spacers Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 42: Asia Pacific Interspinous Spacers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 43: Asia Pacific Interspinous Spacers Market Value Share Analysis (%), by Product, 2021 and 2031
Figure 44: Asia Pacific Interspinous Spacers Market Attractiveness Analysis, by Product, 2022–2031
Figure 45: Asia Pacific Interspinous Spacers Market Value Share (%), by Indication, 2021 and 2031
Figure 46: Asia Pacific Interspinous Spacers Market Attractiveness Analysis, by Indication, 2022–2031
Figure 47: Asia Pacific Interspinous Spacers Market Value Share (%), by End-user, 2021 and 2031
Figure 48: Asia Pacific Interspinous Spacers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 49: Latin America Interspinous Spacers Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 50: Latin America Interspinous Spacers Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 51: Latin America Interspinous Spacers Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 52: Latin America Interspinous Spacers Market Value Share Analysis (%), by Product, 2021 and 2031
Figure 53: Latin America Interspinous Spacers Market Attractiveness Analysis, by Product, 2022–2031
Figure 54: Latin America Interspinous Spacers Market Value Share (%), by Indication, 2021 and 2031
Figure 55: Latin America Interspinous Spacers Market Attractiveness Analysis, by Indication, 2022–2031
Figure 56: Latin America Interspinous Spacers Market Value Share (%), by End-user, 2021 and 2031
Figure 57: Latin America Interspinous Spacers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 58: Middle East & Africa Interspinous Spacers Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2022–2031
Figure 59: Middle East & Africa Interspinous Spacers Market Value Share, by Country/Sub-region, 2021 and 2031
Figure 60: Middle East & Africa Interspinous Spacers Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
Figure 61: Middle East & Africa Interspinous Spacers Market Value Share Analysis (%), by Product, 2021 and 2031
Figure 62: Middle East & Africa Interspinous Spacers Market Attractiveness Analysis, by Product, 2022–2031
Figure 63: Middle East & Africa Interspinous Spacers Market Value Share (%), by Indication, 2021 and 2031
Figure 64: Middle East & Africa Interspinous Spacers Market Attractiveness Analysis, by Indication, 2022–2031
Figure 65: Middle East & Africa Interspinous Spacers Market Value Share (%), by End-user, 2021 and 2031
Figure 66: Middle East & Africa Interspinous Spacers Market Attractiveness Analysis, by End-user, 2022–2031
Figure 67: Medtronic Revenue (US$ Bn) and Y-o-Y Growth (%), 2018–2021
Figure 68: Medtronic R&D Intensity and Sales & Marketing Intensity - Company Level, 2017–2021
Figure 69: Medtronic Breakdown of Net Sales, by Region, 2021
Figure 70: Medtronic Breakdown of Net Sales, by Business Segment, 2021
Figure 71: NuVasive Revenue (US$ Mn) and Y-o-Y Growth (%), 2017–2021
Figure 72: NuVasive R&D Intensity and Sales & Marketing Intensity (%), 2018–2021
Figure 73: NuVasive Breakdown of Net Sales, by Product Line, 2021
Figure 74: NuVasive Breakdown of Net Sales, by Region, 2021
Figure 75: Globus Medical, Inc. Innovative Fusion segment (Globus Medical, Inc.) Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021
Figure 76: Globus Medical, Inc. R&D Investment (US$ Mn), 2018-2021
Figure 77: Globus Medical, Inc. Breakdown of Net Sales, by Segment, 2021
Figure 78: Globus Medical, Inc. Breakdown of Net Sales, by Region, 2021
Figure 79: RTI Surgical Inc. Innovative Fusion segment (Globus Medical, Inc.) Revenue (US$ Mn) & Y-o-Y Growth (%), 2018–2021
Figure 80: RTI Surgical Inc. R&D Investment (US$ Mn), 2017–2021
Figure 81: RTI Surgical Inc. Breakdown of Net Sales, by Segment, 2021
Figure 82: RTI Surgical Inc. Breakdown of Net Sales, by Region, 2021
Figure 83: Zimmer Biomet, Breakdown of Net Sales (%), by Region
Figure 84: Zimmer Biomet, Breakdown of Net Sales (%), by Segment
Figure 85: Zimmer Biomet, Revenue (US$ Mn) & Y-o-Y Growth (%), 2017–2021